Intellectual property and funding: fueling Chinese synbio

• Published in: Trends in biotechnology (Regular ed.) Vol. 42; no. 3; pp. 258 - 260
• Main Authors: Liao, Lijuan, Lou, Yi, Tang, Xianming, Deng, Zixin, Gao, Jiangtao
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.03.2024; Elsevier Limited
• Subjects: Biotechnology industry; business risks; China; Commercialization; Ecosystems; Equity funds; Funding; funding landscape; Genetically modified organisms; Genomics; innovation; Innovations; Intellectual Property; International relations; Investments; Leadership; Policy; Property rights; R&D; Research & development; Synthetic Biology; Technological change; Technology adoption; Venture capital; China; Beijing China; United States > US; innovation; synthetic biology; intellectual property; business risks; funding landscape
• ISSN: 0167-7799; 1879-3096
• DOI: 10.1016/j.tibtech.2023.10.012

As China emerges as a synthetic biology (synbio) global leader, it faces distinct science–society challenges. Our series offers a snapshot of China’s synbio state, emphasizing the intersection and its policy implications. The debut piece elucidates the intellectual property rights (IPR)-funding interplay in China's expanding synbio territory, underlining its key role in driving innovation and commercialization. As China emerges as a synthetic biology (synbio) global leader, it faces distinct science–society challenges. Our series offers a snapshot of China’s synbio state, emphasizing the intersection and its policy implications. The debut piece elucidates the intellectual property rights (IPR)-funding interplay in China's expanding synbio territory, underlining its key role in driving innovation and commercialization.